A novel p53 mutant retained functional activity in lung carcinomas

Jiunn Liang Ko, Ming Chiang Chiao, Shu Lin Chang, Pinpin Lin, Jin Ching Lin, Gwo Tarng Sheu, Huei Lee

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The gene p53 is a critical tumor suppressor that can respond to multiple signals of cellular gatekeepers for growth and division. The mdm2 gene is one of the downstream target genes for transcriptional activation by the product of p53 tumor suppressor gene. Transactivation of mdm2 gene is represented by the presence of a functional P53 protein. To understand the biological function of mutant p53 in tumorigenesis, we constructed a number of p53 mutants by site-directed mutagenesis (H179Y, L194R, S240R, R249S, A276D, E286Q), followed by characterization of each P53 mutant's ability to transactivate mdm2, bax and p21waf. The transactivation properties of p53 mutants were compared by co-transfection with pGL-3-mdm2, pGL-3-bax and pGL-3-p21waf into the P53 null cell line H1299 derived from a non-small cell lung carcinoma. Among them mt p53 S240R and E286Q were shown to have enhanced transactivating activity of pGL3-mdm2, at about 43.2 and 28.2% of the wt p53 vector, respectively, while the remaining four had nearly the same level of activity as the negative control did. Furthermore, data indicated that mt p53 S240R had as high an ability to suppress the growth of the p53 null cell line H1299 as wild type p53. Therefore, mutant p53 alone is an insufficient indicator of poor prognosis. Instead, functional p53 may affect lung cancer prognosis.

Original languageEnglish
Pages (from-to)755-762
Number of pages8
JournalDNA Repair
Volume1
Issue number9
DOIs
Publication statusPublished - Sep 4 2002
Externally publishedYes

Fingerprint

Transcriptional Activation
Genes
Carcinoma
Null Lymphocytes
Lung
Cells
Tumors
Cell Line
p53 Genes
Growth
Site-Directed Mutagenesis
Tumor Suppressor Genes
Mutagenesis
Non-Small Cell Lung Carcinoma
Transfection
Lung Neoplasms
Carcinogenesis
Chemical activation
Neoplasms
Proteins

Keywords

  • Functional p53 mutants
  • MDM2
  • Prognosis
  • Transactivation

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Ko, J. L., Chiao, M. C., Chang, S. L., Lin, P., Lin, J. C., Sheu, G. T., & Lee, H. (2002). A novel p53 mutant retained functional activity in lung carcinomas. DNA Repair, 1(9), 755-762. https://doi.org/10.1016/S1568-7864(02)00094-0

A novel p53 mutant retained functional activity in lung carcinomas. / Ko, Jiunn Liang; Chiao, Ming Chiang; Chang, Shu Lin; Lin, Pinpin; Lin, Jin Ching; Sheu, Gwo Tarng; Lee, Huei.

In: DNA Repair, Vol. 1, No. 9, 04.09.2002, p. 755-762.

Research output: Contribution to journalArticle

Ko, JL, Chiao, MC, Chang, SL, Lin, P, Lin, JC, Sheu, GT & Lee, H 2002, 'A novel p53 mutant retained functional activity in lung carcinomas', DNA Repair, vol. 1, no. 9, pp. 755-762. https://doi.org/10.1016/S1568-7864(02)00094-0
Ko JL, Chiao MC, Chang SL, Lin P, Lin JC, Sheu GT et al. A novel p53 mutant retained functional activity in lung carcinomas. DNA Repair. 2002 Sep 4;1(9):755-762. https://doi.org/10.1016/S1568-7864(02)00094-0
Ko, Jiunn Liang ; Chiao, Ming Chiang ; Chang, Shu Lin ; Lin, Pinpin ; Lin, Jin Ching ; Sheu, Gwo Tarng ; Lee, Huei. / A novel p53 mutant retained functional activity in lung carcinomas. In: DNA Repair. 2002 ; Vol. 1, No. 9. pp. 755-762.
@article{5fb7f5eb339b421ca1e4313685695716,
title = "A novel p53 mutant retained functional activity in lung carcinomas",
abstract = "The gene p53 is a critical tumor suppressor that can respond to multiple signals of cellular gatekeepers for growth and division. The mdm2 gene is one of the downstream target genes for transcriptional activation by the product of p53 tumor suppressor gene. Transactivation of mdm2 gene is represented by the presence of a functional P53 protein. To understand the biological function of mutant p53 in tumorigenesis, we constructed a number of p53 mutants by site-directed mutagenesis (H179Y, L194R, S240R, R249S, A276D, E286Q), followed by characterization of each P53 mutant's ability to transactivate mdm2, bax and p21waf. The transactivation properties of p53 mutants were compared by co-transfection with pGL-3-mdm2, pGL-3-bax and pGL-3-p21waf into the P53 null cell line H1299 derived from a non-small cell lung carcinoma. Among them mt p53 S240R and E286Q were shown to have enhanced transactivating activity of pGL3-mdm2, at about 43.2 and 28.2{\%} of the wt p53 vector, respectively, while the remaining four had nearly the same level of activity as the negative control did. Furthermore, data indicated that mt p53 S240R had as high an ability to suppress the growth of the p53 null cell line H1299 as wild type p53. Therefore, mutant p53 alone is an insufficient indicator of poor prognosis. Instead, functional p53 may affect lung cancer prognosis.",
keywords = "Functional p53 mutants, MDM2, Prognosis, Transactivation",
author = "Ko, {Jiunn Liang} and Chiao, {Ming Chiang} and Chang, {Shu Lin} and Pinpin Lin and Lin, {Jin Ching} and Sheu, {Gwo Tarng} and Huei Lee",
year = "2002",
month = "9",
day = "4",
doi = "10.1016/S1568-7864(02)00094-0",
language = "English",
volume = "1",
pages = "755--762",
journal = "DNA Repair",
issn = "1568-7864",
publisher = "Elsevier",
number = "9",

}

TY - JOUR

T1 - A novel p53 mutant retained functional activity in lung carcinomas

AU - Ko, Jiunn Liang

AU - Chiao, Ming Chiang

AU - Chang, Shu Lin

AU - Lin, Pinpin

AU - Lin, Jin Ching

AU - Sheu, Gwo Tarng

AU - Lee, Huei

PY - 2002/9/4

Y1 - 2002/9/4

N2 - The gene p53 is a critical tumor suppressor that can respond to multiple signals of cellular gatekeepers for growth and division. The mdm2 gene is one of the downstream target genes for transcriptional activation by the product of p53 tumor suppressor gene. Transactivation of mdm2 gene is represented by the presence of a functional P53 protein. To understand the biological function of mutant p53 in tumorigenesis, we constructed a number of p53 mutants by site-directed mutagenesis (H179Y, L194R, S240R, R249S, A276D, E286Q), followed by characterization of each P53 mutant's ability to transactivate mdm2, bax and p21waf. The transactivation properties of p53 mutants were compared by co-transfection with pGL-3-mdm2, pGL-3-bax and pGL-3-p21waf into the P53 null cell line H1299 derived from a non-small cell lung carcinoma. Among them mt p53 S240R and E286Q were shown to have enhanced transactivating activity of pGL3-mdm2, at about 43.2 and 28.2% of the wt p53 vector, respectively, while the remaining four had nearly the same level of activity as the negative control did. Furthermore, data indicated that mt p53 S240R had as high an ability to suppress the growth of the p53 null cell line H1299 as wild type p53. Therefore, mutant p53 alone is an insufficient indicator of poor prognosis. Instead, functional p53 may affect lung cancer prognosis.

AB - The gene p53 is a critical tumor suppressor that can respond to multiple signals of cellular gatekeepers for growth and division. The mdm2 gene is one of the downstream target genes for transcriptional activation by the product of p53 tumor suppressor gene. Transactivation of mdm2 gene is represented by the presence of a functional P53 protein. To understand the biological function of mutant p53 in tumorigenesis, we constructed a number of p53 mutants by site-directed mutagenesis (H179Y, L194R, S240R, R249S, A276D, E286Q), followed by characterization of each P53 mutant's ability to transactivate mdm2, bax and p21waf. The transactivation properties of p53 mutants were compared by co-transfection with pGL-3-mdm2, pGL-3-bax and pGL-3-p21waf into the P53 null cell line H1299 derived from a non-small cell lung carcinoma. Among them mt p53 S240R and E286Q were shown to have enhanced transactivating activity of pGL3-mdm2, at about 43.2 and 28.2% of the wt p53 vector, respectively, while the remaining four had nearly the same level of activity as the negative control did. Furthermore, data indicated that mt p53 S240R had as high an ability to suppress the growth of the p53 null cell line H1299 as wild type p53. Therefore, mutant p53 alone is an insufficient indicator of poor prognosis. Instead, functional p53 may affect lung cancer prognosis.

KW - Functional p53 mutants

KW - MDM2

KW - Prognosis

KW - Transactivation

UR - http://www.scopus.com/inward/record.url?scp=0037019596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037019596&partnerID=8YFLogxK

U2 - 10.1016/S1568-7864(02)00094-0

DO - 10.1016/S1568-7864(02)00094-0

M3 - Article

C2 - 12509279

AN - SCOPUS:0037019596

VL - 1

SP - 755

EP - 762

JO - DNA Repair

JF - DNA Repair

SN - 1568-7864

IS - 9

ER -